APA (7th ed.) Citation

CA, Y., M, J., DO, K., E, C., JE, S., WH, Y., . . . SM, S. (2026). Combined SSTR2-targeted Analogue with 177Lu-DOTATATE radionuclide and octreotide therapy for refractory meningioma: A case report. Frontiers in oncology, 16, 1820428. https://doi.org/10.3389/fonc.2026.1820428

Chicago Style (17th ed.) Citation

CA, Yuen, et al. "Combined SSTR2-targeted Analogue with 177Lu-DOTATATE Radionuclide and Octreotide Therapy for Refractory Meningioma: A Case Report." Frontiers in Oncology 16 (2026): 1820428. https://doi.org/10.3389/fonc.2026.1820428.

MLA (9th ed.) Citation

CA, Yuen, et al. "Combined SSTR2-targeted Analogue with 177Lu-DOTATATE Radionuclide and Octreotide Therapy for Refractory Meningioma: A Case Report." Frontiers in Oncology, vol. 16, 2026, p. 1820428, https://doi.org/10.3389/fonc.2026.1820428.